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Abstract
Cell-mediated transmission and dissemination of sexually-acquired human immunodeficiency virus 1 (HIV-1) in the host
involves the migration of immature dendritic cells (iDCs). iDCs migrate in response to the HIV-1 envelope protein, gp120,
and inhibiting such migration may limit the mucosal transmission of HIV-1. In this study, we elucidated the mechanism of
HIV-1-gp120-induced transendothelial migration of iDCs. We found that gp120 enhanced the binding of Wiskott-Aldrich
Syndrome protein (WASp) and the Actin-Related Protein 2/3 (Arp2/3) complex with b-actin, an interaction essential for the
proper formation of podosomes, specialized adhesion structures required for the migration of iDCs through different
tissues. We further identified Leukocyte-Specific Protein 1 (LSP1) as a novel component of the WASp-Arp2/3-b-actin
complex. Pretreating iDCs with an active fragment of the secretory glycoprotein Slit2 (Slit2N) inhibited HIV-1-gp120-
mediated migration and podosome formation, by inducing the cognate receptor Roundabout 1 (Robo1) to bind to and
sequester WASp and LSP1 from b-actin. Slit2N treatment also inhibited Src signaling and the activation of several
downstream molecules, including Rac1, Pyk2, paxillin, and CDC42, a major regulator of podosome formation. Taken
together, our results support a novel mechanism by which Slit2/Robo1 may inhibit the HIV-1-gp120-induced migration of
iDCs, thereby restricting dissemination of HIV-1 from mucosal surfaces in the host.
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Introduction
After sexual contact with HIV-1, immature DCs (iDCs) capture
the virus in submucosal tissue and then migrate to lymphoid tissues
where they infect CD4
+ T cells. These initial stages of HIV-1
infection result in rapid dissemination of the pathogen throughout
the host [1–5]. Impeding the migration of iDCs could provide a
novel therapeutic strategy to arrest mucosal transmission of HIV-
1. To that end, we assessed Slit2/Robo1, a novel ligand-receptor
pathway, as a means to inhibit HIV-1-induced migration of iDCs.
DC function is dependent on the ability of iDCs to migrate
through different tissues [6–8]. Various migratory stimuli induce
cytoskeletal rearrangements in iDCs and promote the formation of
one dominant protrusion, or lamellipodium, at the leading edge of
the cell, which is oriented in the direction of migration [7]. Non-
migrating cells can also generate lamellipodia; however, in
contrast to migrating DCs, they produce multiple lamellipodia
that protrude at various points around the cell. This prevents the
cells from adopting a polar orientation, and results in no net
motility [9].
In iDCs, numerous, small, round, adhesion points between the
cell and its substratum localize to the leading edge of the cell
[7,10,11]. Recent studies indicate that the proper formation and
localization of these adhesion structures, or ‘‘podosomes,’’ are
required for the migration of iDCs through various tissue barriers
[7,12]. Podosomes are characterized by an actin-rich core, which
is surrounded by a ring-like structure, consisting primarily of
integrins, tyrosine kinases, and adhesion molecules, including
vinculin and paxillin [11,13]. Attachment of iDCs to the
substratum via integrins and their binding partners induces
receptor tyrosine kinase signaling, specifically through PKC
(protein kinase C), Src kinase and Pyk2 (proline-rich tyrosine
kinase-2) [13,14]. Pyk2 activates the Rho GTPase CDC42, which
relieves the conformational autoinhibition of WASp, a major
regulator of the actin cytoskeleton [10]. WASp can then interact
with the Arp2/3 complex and actin to promote actin polymer-
ization and induce the nucleation of actin filaments within the
podosome core [11,15]. Integrin activation can also promote
paxillin to mediate the formation of the podosome ring structure
[13]; CDC42 and Rac1 signaling contribute to ring formation by
activating the adhesion mediator, vinculin, in iDCs [12,13].
Podosomes are highly dynamic. Their average half-life is
between 2 and 12 minutes, during which period the core is
refreshed 2 to 3 times [16,17]. Moreover, the efficient formation of
multiple podosomes at the leading edge of a cell, and their
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[10,17].
Recent studies implicate a role for Slit2 and its ligand, Robo1, in
the migration of several immune cells, including dendritic cells, by
modulating cytoskeletal dynamics [18–22]. Slit2 belongs to the Slit
family of proteins (Slits 1, 2, and 3, in mammals), which are large,
extracellular matrix-secreted and matrix-anchored glycoproteins
[23]. The Slits were first identified as modulators of neuronal
repulsion during development; however, recent studies highlight
their role as multifunctional signaling molecules [13,24,25].
Robo1 is a single-pass transmembrane receptor, which belongs
to the immunoglobulin (Ig) superfamily of cell adhesion molecules
[26,27]. Four Robo proteins (Robos 1–4) have been identified in
mammals [28–30]. The cytoplasmic domains of the Robo
receptors do not possess autonomous catalytic activity; therefore,
they must interact with other signaling molecules or co-receptors
to exert their functional effects [23,31]. Robo 1 signaling is
primarily initiated upon the binding of Slit2 [29,32,33].
To model HIV-induced chemotaxis of iDCs, we used M-tropic
HIV-1 envelope protein, M-gp120, and then explored the effects
of Slit2 on this migration. Since proper podosome function
appears to be necessary for iDC migration, we also examined the
effects of M-gp120 and Slit2 on both podosome formation and
localization in iDCs, specifically, the complexing of key core
podosome-associated proteins, WASp, Arp2/3 and b-actin.
Results
Slit2N Inhibits M-gp120-Induced Migration and
Podosome Formation in iMDDCs
M-gp120 can induce the migration of iDCs in vitro [34], and
Slit2 has been shown to inhibit the migration of various immune
cells, including dendritic cells [19–22]. To explore whether Slit2
might inhibit iDC migration induced by M-gp120, we pretreated
immature, monocyte-derived dendritic cells (iMDDCs) with
Slit2N, an active fragment of Slit2 [35], or with a Slit2 negative
control [36], and plated the cells in the upper chamber of transwell
plates. To the media in the bottom chamber of the transwells, we
added M-gp120, Slit2N or PBS. Consistent with prior results [34],
M-gp120 enhanced the migration of iMDDCs (Figure 1A).
Pretreating the cells with Slit2N significantly inhibited M-gp120-
enhanced migration (Figure 1A). To more closely model the
environment encountered by migrating dendritic cells, we assessed
iMDDC transwell migration through an endothelial cell mono-
layer using the conditions described above. We observed that M-
gp120 greatly enhanced the transendothelial migration of
iMDDCs, and that pretreatment with Slit2N significantly inhibited
this migration (Figure 1B).
Recent studies suggest a central role for podosomes in the
migration of immature dendritic cells and other cell types that
cross tissue boundaries [6–8]. We hypothesized that M-gp120 may
promote iMDDC migration by enhancing the formation of
podosomes in iMDDCs, since Slit2 can modulate the actin
cytoskeleton [25,31,37], a critical component of podosomes.
Podosome formation was evaluated using confocal microscopy.
iMDDCs pretreated with Slit2N, a negative control, or PBS, were
then stimulated with M-gp120 or Slit2N alone. We incubated the
treated iMDDCs with an antibody to vinculin, a protein known to
localize to the podosome ring structure [7]. M-gp120 significantly
enhanced the formation of podosomes, which localized to the
leading edge of the cells (Figure 1C, ‘‘M-gp120’’), a morphology
consistent with migration; pretreatment with Slit2N inhibited
much of the podosome formation induced by M-gp120 (Figure 1C,
‘‘Slit2N + M-gp120’’). While treatment with Slit2N alone did not
appear to alter the size or number of podosomes, their altered
distribution suggested that Slit2N induced the existing podosomes
and focal adhesion-like structures to localize to the periphery of the
cells in a diffuse, evenly distributed manner (Figure 1C, ‘‘Slit2N’’).
To quantify this change, we measured the percent area covered by
podosomes in the cells (with the same images used in Figure 1C)
and the number of podosomes per cell, as described in Materials
and Methods. The area covered by podosomes increased
significantly after treatment with M-gp120, and pretreatment
with Slit2N prevented much of this increase (Figure 1D), while
treatment with Slit2N alone did not significantly alter the area
covered by podosomes (Figure 1D). In addition, the number of
podosomes per cell in iMDDCs increased significantly after M-
gp120 treatment, and pretreatment with Slit2N inhibited this M-
gp120-induced increase (Figure 1E). Again, treatment with Slit2N
alone had no significant affect on the number of podosomes
(Figure 1E). Taken together, these data indicate that M-gp120
may enhance iMDDC migration by enhancing the number of
podosomes per cell and inducing them to cluster to the leading
edge of the cells, and that Slit2N can prevent M-gp120-induced
migration and transendothelial migration of iMDDCs. Our
observations also suggest that Slit2N may inhibit iMDDC
migration by depolarizing the cells, and inhibiting the formation
and aggregation of podosomes to the leading edge.
LSP1 Contributes to M-gp120-Induced Migration and
Podosome Formation in iMDDCs
Earlier studies show that in iDCs, M-gp120 can activate LSP1
and promote its binding to actin [34], a major constituent of the
podosome core [7,11,13]. Moreover, this binding appeared to be
critical for iDC migration [34]. To examine the potential role of
LSP1 in M-gp120-induced podosome formation in iDCs, we
examined by confocal microscopy the expression of LSP1 in
untreated iMDDCs and in those incubated with M-gp120. M-
gp120 greatly enhanced the localization of LSP1 to podosomes at
the leading edge of the cells (Figure 2A, ‘‘M-gp120’’), suggesting a
role in podosome formation and function. To investigate this
further, we transiently transfected iMDDCs with non-targeted
(NT) siRNAs or LSP1-specific siRNAs, and confirmed the
reduction in LSP1 expression by Western blot analysis
(Figure 2B). LSP1 expression was quantitated by densitometry.
Consistent with the Western blot analysis, iMDDCs transfected
with LSP1-specific siRNAs expressed significantly lower levels of
LSP1 than those transfected with non-targeted siRNAs (Figure 2C).
We treated both groups of transfectants with M-gp120, and
examined vinculin (to highlight podosomes) and LSP1 expression
by confocal microscopy. M-gp120 induced the formation and
leading edge localization of podosomes in the iMDDCs with
endogenous LSP1 expression (Figure 2D, upper left panel). M-
gp120 also induced the localization of LSP1 to the podosomes at
the leading edge of the NT-siRNA transfected cells (Figure 2D,
lower left panel). In iMDDCs with reduced LSP1 expression, M-
gp120 induced significantly fewer podosomes, and generated a less
focused, weaker, leading edge structure than those with endoge-
nous LSP1 expression (Figure 2D, upper right panel). Further-
more, LSP1 was expressed diffusely throughout the cells even after
M-gp120 treatment (Figure 2D, lower right panel). These data
suggest that sufficient levels of LSP1 may be required for M-
gp120-induced podosome formation and their localization to the
leading edge of iMDDCs.
To explore the impact of reduced LSP1 expression on M-
gp120-mediated dendritic cell function, we compared the M-
gp120-induced transwell migration of iMDDCs transfected with
NT-siRNAs or with LSP1-specific siRNAs, to unstimulated
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the iMDDCs transfectants with endogenous LSP1 expression
(Figure 2E, ‘‘NT-siRNA’’); however, M-gp120-mediated migra-
tion was severely impeded in the transfectants with reduced levels
of LSP1 (Figure 2E, ‘‘LSP1-siRNA’’). These results suggest that
sufficient levels of LSP1 are required for M-gp120-enhanced
migration of iMDDCs. Taken together, our data suggest that
LSP1 plays a role in M-gp120-induced podosome formation and
migration of iMDDCs.
Slit2N Inhibits the M-gp120-Enhanced Association of
LSP1 with the WASp-Arp2/3-b-Actin Complex in iMDDC
Podosomes
Upon activation, CDC42 interacts with WASp, the Arp2/3
complex, and cytoskeletal actin (b-actin), and induces the
nucleation and polymerization of monomeric actin into actin
filaments within the podosome core, which promotes podosome
formation and iDC migration [38]. In addition, a recent study
demonstrated that the binding of LSP1 and actin is important for
M-gp120-induced chemotaxis of iDCs [34]. We examined the
Figure 1. Slit2N inhibits HIV-1-gp120-induced migration and podosome formation of iMDDCs. (A) iMDDC transwell migration: cells were
incubated with Slit2N, Slit2 negative control, or media alone for 2 hours, then seeded to the upper compartments of transwell chambers. Media +/2
M-gp120 or Slit2N was added to the bottom compartments of the chambers. After 3 hours, iMDDCs that had migrated to the lower chambers were
counted by hemocytometer. Data indicate the mean 6 SD of 5 independent experiments (***p#0.001). (B) iMDDC transendothelial migration:
HUVECs were seeded into the upper compartment of transwell chambers and incubated at 37uC, 5% CO2, to confluency. iMDDCs were incubated
with Slit2N, Slit2 negative control, or media alone for 2 hours, then seeded to the upper compartments of transwell chambers. Media +/2 M-gp120
or Slit2N was added to the bottom compartments of the chambers. After 8 hours, iMDDCs that had migrated to the lower chambers were counted by
hemocytometer. Data indicate the mean 6 SD of 5 independent experiments (***p#0.001). (C) Vinculin expression by confocal microscopy. iMDDCs
were cultured on chamber slides and left untreated or incubated with M-gp120, Slit2N then M-gp120, or Slit2N alone (Slit2N incubation: 2 hours; M-
gp120 incubation: 1 hour) before fixing and staining cells. Green = Vinculin; Blue = DAPI. Scale bars =2 mm. Arrows indicate a dense accumulation
of podosomes at the cell’s leading edge (‘‘M-gp120’’ image), a reduced number of podosomes clustered at a weaker leading edge (‘‘Slit2N + M-
gp120’’ image), and a reduced number of podosomes localized around the cell’s periphery (‘‘Slit2N’’ image). Representative images are shown. (D)
Percent of cell area covered by podosomes in the slides from Figure 1C, as described in Materials and Methods. (E) Number of podosomes per cells as
described in Materials and Methods. Cells were treated as above. Data indicate the mean 6 SD of 3 independent experiments x 50 cells per
experimental condition (***p#0.001).
doi:10.1371/journal.pone.0048854.g001
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WASp-Arp2/3-b-actin complex in iMDDCs. We collected lysates
from untreated iMDDCs, and from those incubated with M-gp120
for 30 minutes and 2 hours. Using LSP1 immunoprecipitation
and Western blot analysis, we examined the effects of M-gp120 on
the interaction of LSP1 with WASp, Arp2/3, and b-actin
(Figures 3A and 3B). M-gp120 enhanced the association LSP1
with all three proteins; moreover, their association with LSP1
increased with time (Figures 3A and 3B). These data suggest that
the M-gp120-mediated association of LSP1 with the WASp-Arp2/
3-b-actin complex within the podosome core may be important for
podosome formation of iMDDCs.
To investigate if Slit2N can inhibit this association, we collected
lysates from untreated iMDDCs, and from iMDDCs incubated
with M-gp120, Slit2 negative control + M-gp120, Slit2N + M-
gp120, and Slit2N alone. After LSP1 immunoprecipitation, we
examined by Western blot analysis the interaction of LSP1 with
WASp, Arp2/3, and b-actin (Figures 3C and 3D). M-gp120
enhanced the binding of LSP1 to all three proteins, and
preincubation with Slit2N inhibited much of the M-gp120-
enhanced binding (Figures 3C and 3D). Treatment with Slit2N
alone inhibited the association of LSP1 with WASp, Arp2/3, and
b-actin as much or more than the combination of Slit2N and M-
gp120 (Figures 3C and 3D).
To explore if M-gp120 or Slit2N may affect this association by
altering expression levels, we examined by Western blot analysis
their expression in iMDDCs under the same conditions. The levels
of each of the four proteins in iMDDCs were identical under all
conditions investigated (Figure 3E), indicating that neither M-
gp120 nor Slit2N affected the expression of LSP1, WASp, Arp2/3
or b-actin in iMDDCs; therefore, M-gp120 and Slit2N must
modulate the association among these proteins by an alternative
mechanism.
To explore this possibility, we examined by confocal microscopy
the expression and colocalization of LSP1 with WASp, Arp2/3
and ß-actin in iMDDCs. Untreated iMDDCs displayed multiple
lamellipodia or no distinct lamellipodium, morphologies consistent
with lack of motility (Figure 4A, ‘‘UN’’ panels). In these cells, LSP1
colocalized moderately with WASp and b-actin at the cell
periphery, in multiple lamellipodia (Figure 4A); however, Arp2/
3 was diffusely expressed and did not appear to colocalize with
LSP1 (Figure 4A). After treatment with M-gp120, the cells became
Figure 2. LSP1 contributes to M-gp120-induced migration and podosome formation of iMDDCs. (A) LSP1 expression by confocal
microscopy. iMDDCs were cultured on chamber slides and left untreated or incubated with M-gp120 for 1 hour before fixing and staining cells. Red
= LSP1; Blue = DAPI. Scale bars =2 mm. Arrow indicates the cell’s leading edge. Representative images are shown. (B) Representative Western blot
analysis of LSP1 expression in untreated iMDDCs and in iMDDCs transfected with NT-siRNAs or LSP1-specific siRNAs. b-actin used as loading control.
(C) Quantitative analysis of LSP1 expression in untreated iMDDCs and in iMDDCs transfected with NT-siRNAs or LSP1-specific siRNAs. The band
intensity in each lane of 3 independent Western blots (as in Figure 2B) was determined by densitometry. Percent expression was calculated relative to
the untreated control cells, whose LSP1 levels were established as 100%. Data represent the mean 6 SD of 3 independent experiments (**p#0.01).
(D) LSP1 and vinculin expression by confocal microscopy. iMDDCs transfected with NT-siRNAs or with LSP1-specific siRNAs were cultured on chamber
slides and incubated with M-gp120 for 1 hour before fixing and staining cells. Green = Vinculin; Red = LSP1; Blue = DAPI. Scale bars =2 mm. Arrows
in the upper left panel and lower left panel indicate a dense accumulation of podosomes at the cells’ leading edge; while arrows in the upper right
panel and lower right panel indicate fewer podosomes, more diffusely distributed throughout cells without a distinct leading edge. Represent-ative
images are shown. (E) Transwell Migration: iMDDCs and iMDDCs transfected with NT-siRNAs or with LSP1-specific siRNAs were seeded to the upper
compartments of transwell chambers. Media +/2 M-gp120 was added to the bottom compartments of the chambers. After 2 hours, cells that had
migrated to the lower chambers were counted by hemocytometer. Data indicate the mean 6 SD of 4 independent experiments (**p#0.01).
doi:10.1371/journal.pone.0048854.g002
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some numbers increased and localized to the cells’ leading edge,
morphologies consistent with migration (Figure 4A, ‘‘M-gp120’’
panels). In these cells, LSP1 strongly colocalized with WASp,
Arp2/3, and b-actin in the podosomes at the leading edge of
iMDDCs (Figure 4A, ‘‘M-gp120’’ panels). When cells were
pretreated with Slit2N before incubation with M-gp120, they
were less polarized, the leading edge was less distinct, or multiple
lamellipodia replaced the single leading edge (Figure 4A, ‘‘Slit2N +
M-gp120’’ panels). The colocalization of LSP1 with WASp and b-
actin to the lamellipodia was weaker, and again, Arp2/3 was
diffusely distributed throughout the cell with little or no
colocalization with LSP1 (Figure 4A, ‘‘Slit2N + M-gp120’’ panels).
After treatment with Slit2N alone, cell morphology and the
colocalization of LSP1 with WASp, Arp2/3 and b-actin was very
similar to that of untreated iMDDCs (Figure 4A, ‘‘Slit2N’’ panels).
(Note: merged images at a lower magnification are provided in
Supporting Information (Figure S1) to demonstrate that the
images displayed in Figure 4A are representative of the overall
cultures.) To quantitate these colocalization data we used
VolocityH software as described in Materials and Methods. Briefly,
colocalization of proteins in untreated cells was considered ‘‘1,’’
and fold change in protein colocalization in the treated cells was
calculated relative to the untreated control. Consistent with the
confocal images, M-gp120 enhanced the colocalization of LSP1
with WASp, Arp2/3, and b-actin; pretreatment with Slit2N
significantly inhibited this M-gp120-induced colocalization; and
colocalization of the proteins in cells treated with Slit2N alone was
Figure 3. Slit2N inhibits M-gp120-induced association of LSP1, WASp, Arp2/3, and b-actin in iMDDCs. (A) Representative
immunoprecipitation of LSP1 with WASp, Arp2 and b-actin in iMDDCs incubated for various times with M-gp120. LSP1 used as loading control. (B)
Quantitative analysis of the immunoprecipitation of LSP1 with WASp, Arp2 and b-actin in iMDDCs incubated for various times with M-gp120. LSP1
used as loading control. The band intensity in each lane was determined by densitometry. The fold change was determined by calculating the value
of each lane vs. the unstimulated control (0 h, M-gp120 ‘‘2’’). Data represent the mean 6 SD of 3 independent experiments (*p#0.05, **p#0.01). (C)
Representative immunoprecipitation of LSP1 with WASp, Arp2 and b-actin in untreated iMDDCs, and in iMDDCs incubated with M-gp120, Slit
negative control then M-gp120, Slit2N then M-gp120, or Slit2N alone. LSP1 used as loading control. (D) Quantitative analysis of the
immunoprecipitation of LSP1 with WASp, Arp2 and b-actin in untreated iMDDCs, and in iMDDCs incubated with M-gp120, Slit negative control then
M-gp120, Slit2N then M-gp120, or Slit2N alone. LSP1 used as loading control. The band intensity in each lane was determined by densitometry. The
fold change was determined by calculating the value of each lane vs. the unstimulated control. Data represent the mean 6 SD of 3 independent
experiments (*p#0.05, **p#0.01). (E) Representative Western blot analysis of LSP1, WASp, Arp2 and b-actin in untreated iMDDCs, and in iMDDCs
incubated with M-gp120, Slit negative control then M-gp120, Slit2N then M-gp120, or Slit2N alone.
doi:10.1371/journal.pone.0048854.g003
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indicate that M-gp120 induced the colocalization of LSP1 with
WASp, Arp2/3 and b-actin to the podosomes at the leading edge
of migrating iMDDCs, and that Slit2N inhibited this colocaliza-
tion. These data suggest that M-gp120 and Slit2N may enhance or
inhibit, respectively, podosome formation and iMDDC migration,
by modulating the association of LSP1 with WASp, Arp2/3 and b-
actin.
Slit2N Alters the Localization and Binding of Robo1 to
WASp and LSP1 in M-gp120-Treated iMDDCs
The signaling between Slit2 and its binding partner, Robo 1,
inhibits glioma cell migration in vitro and in vivo by inactivating
CDC42-GTP [39], a Rho GTPase which induces the complexing
of WASp and the Arp2/3 complex with actin to promote
podosome formation. Also, Slit2 can modulate the interaction
between Robo1 and WASp in multiple cell types, including
smooth muscle cells and neurons [40,41]. We hypothesized that
Slit2N may inhibit iMDDC migration by altering the interaction
between Robo1 and key components of the WASp-Arp2/3-b-
actin-LSP1 podosome complex. We treated iMDDCs as indicated
in Figures 5A and 5B, and after Robo1 immunoprecipitation,
examined by Western blot analysis the interactions of Robo1 with
WASp, b-actin, and LSP1 (Figures 5A and 5B). The weak
interaction between Robo1 and WASp in untreated iMDDCs, and
in those treated with M-gp120, or Slit2 negative control + M-
gp120, was considerably enhanced after treatment with Slit2N +
M-gp120, or with Slit2N alone (Figures 5A and 5B). Robo1 and
LSP1 associated very strongly in iMDDCs after treatment with
Slit2N alone, with little or no interaction under any other
conditions examined (Figures 5A and 5B). There was a moderate
interaction between Robo1 and b-actin under all experimental
conditions (Figures 5A and 5B).
To ascertain if M-gp120 or Slit2N may affect Robo1’s
association with LSP1 or WASp by altering the expression level
of Robo1 in iMDDCs, we used Western blot analysis. The levels of
Robo1 were identical under all conditions examined (Figure 5C).
These data indicate that neither M-gp120 nor Slit2N altered
Robo1 levels in iMDDCs, however, the IP data (Figures 5A and
5B) suggest that Slit2N may enhance the association of Robo1
with LSP1 and WASp in these cells.
To explore this further, we examined by confocal microscopy
the colocalization of Robo1 with WASp and LSP1 in iMDDCs
(Figure 5D). In untreated iMDDCs, Robo1, WASp, and LSP1
were diffusely expressed with little or no colocalization (Figure 5D,
‘‘UN’’ panels). When the cells were incubated with M-gp120, they
appeared to polarize and to develop a distinct leading edge
(Figure 5D, ‘‘M-gp120’’ panels). This morphology is consistent
with prior results demonstrating that M-gp120 enhances the
migration of iMDDCs ([34], Figures 1A and 1B); however, Robo1
and WASp did not appear to colocalize, and Robo1 and LSP1 did
not colocalize to the podosomes at the leading edge of the cells
(Figure 5D, ‘‘M-gp120’’ panels). When iMDDCs were treated with
Slit2N + M-gp120, and with Slit2N alone, the cells no longer
formed one clearly defined leading edge; instead, multiple
lamellipodia-like structures were distributed around the periphery
of the cells, to which Robo1 strongly colocalized with WASp and
LSP1 (Figure 5D, ‘‘Slit2N + M-gp120’’ and ‘‘Slit2N’’ panels).
(Note: merged images at a lower magnification are provided in
Supporting Information (Figure S2) to demonstrate that the
images displayed in Figure 5D are representative of the overall
cultures.) We quantitated these colocalization data as previously
described. Consistent with the confocal images, colocalization of
Robo1 with WASp or LSP1 in untreated iMDDCs was the lowest
of all conditions examined, treatment with M-gp120 alone
induced little or no enhanced colocalization, and treatment with
Slit2N + M-gp120 or Slit2N alone significantly enhanced the
colocalization of the aforementioned proteins (Figure 5E).
Taken together, these data suggest that Slit2N may inhibit the
M-gp120-induced migration of iMDDCs by enhancing the
colocalization of Robo1 with WASp and LSP1. Based on the
morphology of the cells, this colocalization of Robo1 with WASp
and LSP1 appears to inhibit cellular polarization and the
formation of one predominant leading edge, which is consistent
with our data demonstrating that Slit2N inhibits the M-gp120-
induced migration and transendothelial migration of iMDDCs
(Figures 1A and 1B).
Slit2N Inhibits M-gp120-Induced Src Signaling, and
Activation of its Downstream Targets, Pyk2, CDC42, Rac1,
and Paxillin
Podosomes are required for the migration of iDCs, and other
cell types that must travel across tissue barriers [6,7,11,12]. Three
primary regulators of podosome formation and disassembly in
dendritic cells are Rho GTPase proteins (including CDC42 and
Rac1), actin regulatory pathways, and the phosphorylation of
receptor tyrosine kinases (including Src and Pyk2) [11,13]. Robo/
Slit interactions can affect migration by modulating Rho GTPases
[21,25]; therefore, we treated iMDDCs as described in Figures 6A
and 6B, and examined the activation of CDC42 and Rac1. Since
activated CDC42 and Rac1 will bind to PAK-1, we collected cell
lysates and incubated them with beads coated with PAK-1. By
Western blot analysis we examined the levels of CDC42 and Rac1
that bound to PAK-1. We found that M-gp120 enhanced the basal
activation of CDC42, and pretreatment with Slit2N completely
inhibited this activation (Figures 6A and 6B). Likewise, Slit2N
alone inhibited nearly all of the basal CDC42 activation
(Figures 6A and 6B). While the effects were not as pronounced
for Rac1, M-gp120 did enhance Rac1 activation, and pretreat-
ment with Slit2N inhibited this activation (Figures 6A and 6B). Src
kinase signaling can modulate podosome formation by activating
Pyk2 or PI3K [13], and Pyk2 plays a role in the M-gp120-induced
migration of dendritic cells [34]. In iMDDCs, we examined total
and phosphorylated Src and Pyk2 under the conditions described
above. We found that total Src and total Pyk2 levels remained
constant under all conditions examined, and M-gp120 enhanced
Src phosphorylation, which was inhibited by pretreatment with
Slit2N (Figures 6C and 6D). Slit2N also inhibited the M-gp120-
enhanced phosphorylation of Pyk2 (Figures 6C and 6D). Src
signaling can modulate the activation of paxillin [14], an adhesion-
mediating molecule involved in the formation of the podosome
ring structure [11]; therefore, we examined paxillin levels under
the experimental conditions just described. M-gp120 greatly
enhanced the phosphorylation of paxillin in iMDDCs, and
pretreatment with Slit2N significantly inhibited this M-gp120-
enhanced activation, whereas total paxillin levels remained
constant under all conditions examined (Figures 6C and 6D).
Taken together, these data suggest that M-gp120 enhances
migration and podosome formation in iMDDCs by activating
Rac1 signaling through Src and its downstream targets, Pyk2,
CDC42 and paxillin.
Discussion
The ability of iDCs to capture sexually transmitted HIV-1 in the
submucosa and localize to lymphatic tissues where they infect
CD4
+ T cells with the virus, depends, at least in part, on the
migratory nature of iDCs [3,4]. Inhibiting the migration of HIV-1-
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PLOS ONE | www.plosone.org 6 October 2012 | Volume 7 | Issue 10 | e48854Figure 4. Slit2N inhibits M-gp120-induced colocalization of LSP1, WASp, Arp2/3, and b-actin to iMDDC podosomes. (A) Expression
and colocalization of LSP1, WASp, Arp2/3 and b-actin by confocal microscopy. iMDDCs were cultured on chamber slides and left untreated or
incubated with M-gp120, Slit2N then M-gp120, or Slit2N alone (Slit2N incubation: 2 hours; M-gp120 incubation: 1 hour) before fixing and staining
cells. Green = LSP1; Red = WASp, Arp2/3, or b-actin, as indicated; Yellow/orange = merge; Blue = DAPI. In the ‘‘Merge’’ images: no arrow indicates a
rounded cellular morphology, which is characteristic of non-migrating iMDDCs; one arrow indicates a single lamellipodium, densely populated with
podosomes, at the leading edge of a polarized cell, which is characteristic of migrating iMDDCs; multiple arrows indicate multiple lamellipodia/focal
adhesions with various orientations, which are characteristic of non-migrating iMDDCs. Scale bars =2 mm. Representative images are shown. (B)
Quantitative analysis of the colocalization of LSP1 with (I) WASp, (II) Arp2/3 and (III) b-actin in iMDDCs, under conditions identical to Figure 4B, using
confocal microscopy and VolocityH software. Data represent the mean 6 SD of 3 independent experiments x 3 randomly chosen cells per condition
(*p#0.05,**p#0.01).
doi:10.1371/journal.pone.0048854.g004
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PLOS ONE | www.plosone.org 7 October 2012 | Volume 7 | Issue 10 | e48854Figure 5. Slit2N enhances Robo1, WASp, and LSP1 association, and their colocalization around the periphery of iMDDCs. (A)
Representative immunoprecipitation of Robo1 with WASp, LSP1, and b-actin in untreated iMDDCs, and in iMDDCs incubated with M-gp120, Slit
negative control then M-gp120, Slit2N then M-gp120, or Slit2N alone. Robo1 used as loading control. (B) Quantitative analysis of the
immunoprecipitation of Robo1 with WASp, LSP1, and b-actin in untreated iMDDCs, and in iMDDCs incubated with M-gp120, Slit negative control
then M-gp120, Slit2N then M-gp120, or Slit2N alone. Robo1 used as loading control. The band intensity in each lane was determined by densitometry.
The fold change was determined by calculating the value of each lane vs. the unstimulated control. Data represent the mean 6 SD of 3 independent
experiments (*p#0.05, **p#0.01). (C) Representative Western blot analysis of Robo1 expression in untreated iMDDCs, and in iMDDCs incubated with
M-gp120, Slit2 negative control then M-gp120, Slit2N then M-gp120, or Slit2N alone. b-actin used as loading control. (D) Expression and
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the host, and the infection of target CD4
+ T cells.
The HIV-1 envelope protein, M-gp120, which is critical for the
attachment and infection of CD4
+ T cells, can induce the
migration of iDCs in vitro [34,42]. This migration likely reflects the
chemoattraction of iDCs to HIV-1 in vivo. We expanded on these
prior data by demonstrating that M-gp120 induced the migration
of iDCs through an endothelial cell monolayer, and the formation
and localization of podosomes to the leading edge of iMDDCs.
Since recent studies suggest a central role for podosomes in the
colocalization of Robo1, WASp, and LSP1 by confocal microscopy. iMDDCs were cultured on chamber slides and left untreated or incubated with M-
gp120, Slit2N then M-gp120, or Slit2N alone (Slit2N incubation: 2 hours; M-gp120 incubation: 1 hour) before fixing and staining cells. Red = Robo1;
Green = WASp or LSP1, as indicated; Yellow/orange = merge; Blue = DAPI. In the ‘‘Merge’’ images: no arrow indicates a rounded cellular
morphology with diffuse or no colocalization of the proteins; one arrow indicates a single lamellipodium, but little or no colocalization of proteinst o
the podosomes at the leading edge of the iMDDC; multiple arrows indicate colocalization of proteins around the periphery of the cells, or in multiple
lamellipodia with various orientations. Scale bars =2 mm. Representative images are shown. (E) Quantitative analysis of the colocalization of Robo1
with (I) WASp and (II) LSP1 in iMDDCs, under conditions identical to Figure 5D, using confocal microscopy and VolocityH software. Data represent the
mean 6 SD of 3 independent experiments x 3 randomly chosen cells per condition (**p#0.01, ***p#0.001 for cells treated with Slit2N, then M-gp120
or just Slit2N vs. untreated control).
doi:10.1371/journal.pone.0048854.g005
Figure 6. Slit2N inhibits M-gp120-induced signaling through Src, and activation of Pyk2, CDC42, Rac1, and paxillin. (A) CDC42 and
Rac1 activation assay: Lysates of untreated iMDDCs, and iMDDCs incubated with M-gp120, Slit2 negative control then M-gp120, Slit2N then M-gp120,
or Slit2N alone were incubated with activated PAK1-conjugated agarose. Binding of activated CDC42 and Rac1 to PAK1 was visualized by Western
blot analysis as described in Materials and Methods. PAK1 used as loading control. Representative assay is shown. (B) Quantitative analysis of the
CDC42 and Rac1 activation by Western blot analysis. The band intensity in each lane was determined by densitometry. The fold change was
determined by calculating the value of each lane vs. the unstimulated control or as indicated. Data represent the mean 6 SD of 3 independent
experiments (*p,0.05, **p#0.01). (C) Representative Western blot analysis of total and phosphorylated Src, Pyk2 and paxillin in untreated iMDDCs,
and in iMDDCs incubated with M-gp120, Slit2 negative control then M-gp120, Slit2N then M-gp120, or Slit2N alone. GAPDH used as loading control.
(D) Quantitative analysis of phosphorylated Src, Pyk2 and paxillin by Western blot analysis in untreated iMDDCs, and in iMDDCs incubated with M-
gp120, Slit2 negative control then M-gp120, Slit2N then M-gp120, or Slit2N alone. GAPDH used as loading control. The band intensity in each lane
was determined by densitometry. The fold change was determined by calculating the value of each lane vs. the unstimulated control or as indicated.
Data represent the mean 6 SD of 3 independent experiments (*p,0.05, **p#0.01).
doi:10.1371/journal.pone.0048854.g006
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formation and distribution of podosomes may be a novel
mechanism whereby M-gp120 promotes iDC migration.
Podosomes are characterized by a two-part architecture: an
actin-rich core and associated proteins, surrounded by a ring-like
structure containing proteins such as vinculin and talin, which link
integrins to the core [13,16]. Various components of the
podosome core and their interactions have been well-character-
ized, namely, activation of the Rho GTPase, CDC42, induces the
complexing of WASp and the Arp2/3 complex with actin, to
promote actin polymerization and podosome formation [38].
Therefore, we examined the effect of M-gp120 on the expression,
and cellular localization and colocalization of WASp, Arp2/3 and
b-actin in iMDDCs. Consistent with the ability of M-gp120 to
induce the migration of iDCs, we found that M-gp120 enhanced
podosome formation, their localization to the cells’ leading edge,
and the complexing of WASp and Arp2/3 with b-actin in the
podosomes of migrating iMDDCs. In addition, we identified
LSP1, a leukocyte-specific, actin-binding protein [43] that
enhances iDC migration by remodeling the actin cytoskeleton
[44,45], as a novel component of the WASp-Arp2/3-b-actin
complex in iMDDC podosomes. We also demonstrated that
sufficient levels of LSP1 are important for podosome formation
and iMDDC migration.
The Slit proteins, which signal when bound to the cognate
Robo receptors, were first characterized as developmental
neuronal guidance molecules [24–27]. They have also been
shown to modulate the permeability of lymphatic endothelium
[46], and the migration of endothelial cells [47], various cancer
cells [48–50], and most recently, immune cells, including
monocytes [51], neutrophils [20,21], eosinophils [21], Langerhan
cells [22], and dendritic cells [22,34]. With the exception of
eosinophils, whose migration was variously enhanced or inhibited,
depending on the specific route of administration [21], Slit2 (when
bound to Robo1) inhibited the migration of all types of immune
cells examined [20,22,51]. Consistent with these data, we found
that pretreatment with Slit2N significantly inhibited the M-gp120-
induced migration of iMDDCs in vitro. Moreover, we determined
that the binding of Slit2N to Robo1 inhibited iMDDC migration
by preventing the formation and proper intracellular localization
of podosomes in M-gp120-treated cells. There was a consistent
interaction between Robo1 and b-actin, and treatment with Slit2N
enhanced the association of WASp and LSP1 with Robo1.
Podosome formation in leukocytes is primarily regulated by
tyrosine kinase signaling through Src, PI3K and Pyk2, which
activate various Rho GTPases, including Rac1/2, RhoA and
CDC42 [7,13,14]. Slit can inhibit the activation of Rho GTPases
[21,25]. In light of recent studies demonstrating the inhibition of
immune cell migration by Slit2/Robo1 [19,20,22,51], we
hypothesized that Slit2/Robo1 may inhibit iMDDC migration
through signaling pathways which modulate podosome formation.
Supporting our hypothesis, we observed that Slit2/Robo1
inhibited the M-gp120-induced activation of c-Src, Pyk2, paxillin,
Rac1 and CDC42.
Based on these observations, we propose the following model as
a potential molecular mechanism by which Slit2/Robo1 may
inhibit the HIV-1-gp120-induced migration of iMDDCs (Figure 7).
Upon binding to the cell surface receptor CCR5, HIV-1-gp120
induces signaling through c-Src which results in the activation of
several GTPases, including CDC42. Activated CDC42 induces
the complexing of WASp, LSP1 and the Arp2/3 complex with b-
actin, which enhances podosome formation and migration
(Figure 7A). When Slit2 binds to Robo1, however, signaling
through c-Src and the activation of Rho GTPases, including
CDC42, is blocked. Without CDC42 activation, LSP1 and WASp
preferentially bind to Robo1, which appears to sequester these
proteins away from the WASp-Arp2/3-LSP1-b-actin podosome
core complex, and to inhibit podosome formation and iMDDC
migration (Figure 7B).
In summary, we found that the interaction between Slit2N and
Robo1 inhibited the HIV-1-gp120-induced transendothelial mi-
gration of iDCs, a function believed to be key in the initial homing
to and internalization of HIV-1 by iDCs, and for the transmission
of HIV-1 by iDCs to CD4
+T cells in vivo. Moreover, we
demonstrated a strong positive correlation between HIV-1-
gp120-induced podosome formation and localization to the
leading edge of iMDDCs, with enhanced transendothelial
migration. Similarly, when podosome formation, podosome
localization, and the colocalization of podosome core proteins
were inhibited by Slit2/Robo1 activation, iMDDC migration was
inhibited. These findings encourage further studies of the
inhibition of dendritic cell migration as a potential clinical strategy
to limit the mucosal transmission of HIV-1.
Figure 7. Hypothetical model of the effects of Slit2/Robo1 on HIV-1-gp120-induced podosome formation and migration of
iMDDCs. (A) HIV-1-gp120 induces podosome formation, and the migration of iMDDCs. (B) Slit2/Robo1 inhibit HIV-1-gp120-induced podosome
formation and migration of iMDDCs.
doi:10.1371/journal.pone.0048854.g007
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Cell lines
Human umbilical vein endothelial cells (HUVECs) were
purchased from Clonetics, now, Lonza Walkersville, Inc., Walk-
ersville, MD.
Preparation of Monocyte-Derived Dendritic Cells
(iMDDCs) from Blood
Buffy coat was procured from Transfusion Medicine, Children’s
Hospital, Boston, MA, and from the Blood Transfusion Service,
Massachusetts General Hospital, Boston, MA, with strict compli-
ance to the Beth Israel Deaconess Medical Center Committee on
Clinical Investigations (CCI) protocol #2008-P-000418. Buffy
coat was readily available at these institutions for research
purposes, therefore, we did not have to depend on consented
donors. In addition, for this work, buffy coat was provided without
identifiers. CD14
+ monocytes were isolated from the buffy coats,
using a human CD14
+ negative selection kit (StemCell Technol-
ogies, Vancouver, BC, Canada) per manufacturer’s instructions.
Monocytes were cultured in complete RPMI media, supplemented
with 50 ng/ml human granulocyte macrophage colony-stimulat-
ing factor and 50 ng/ml human interleukin-4 (PeproTech, Rocky
Hill, NJ). After 6 days, iDCs were characterized by evaluating the
expression of DC-SIGN, CD14, HLA-DR, and CD1a with
appropriate antibodies using FACS analysis.
Antibodies and Reagents
The N-terminal, active segment of Slit 2 (Slit2N) and its
negative control were prepared as described [36]. M-tropic gp120
was obtained through the NIH AIDS Research and Reference
Reagent Program, Division of AIDS, NIAID, NIH. LSP1
antibodies were obtained from BD Transduction Laboratories
(San Jose, CA) and Santa Cruz Biotechnologies (Santa Cruz, CA).
Vinculin antibody was obtained Sigma Aldrich Corp (St. Louis,
MO). Robo1 antibodies were obtained from Abcam (Cambridge,
MA) and Sigma Aldrich Corp. WASP, b-actin, Arp2, p-Src, p-
Pyk2, p-Paxillin and GAPDH antibodies were obtained from
Santa Cruz Biotechnology. Fluorescein isothiocyanate (FITC)–
conjugated antibodies CD1a (clone HI149), CD14, and CCR5;
phycoerythrin (PE)–conjugated antibodies DC-SIGN and
CXCR4; allophycocyanin (APC)–conjugated HLA-DR and
CD4; and isotype controls were obtained from BD Pharmingen,
San Diego, CA.
Immunoprecipitation and Western Blot Analysis
iMDDCs were pretreated with Slit2N (1 mg/ml) or Slit negative
control (1 mg/ml) for 2 hours in serum-free RPMI 1640, then
stimulated with M-gp120 (10 nM) for 2 hours. Cells were then
washed, and lysed with RIPA buffer containing protease
inhibitors. For immunoprecipitation, equal amounts of protein
(0.5 to 1.0 mg) were precleared with protein A-sepharose beads,
and incubated with specific antibodies for 2 hours at 4uC. Then,
the immune complexes were precipitated with protein A-
sepharose beads overnight at 4uC, followed by centrifugation.
The beads were washed thrice with RIPA buffer, once with PBS,
and suspended in 2X Laemmli buffer. Equivalent amounts of
protein extract were run on a 4 to 12% gradient acrylamide gel
(NuPAGE Bis-Tris gel; Invitrogen, Carlsbad, CA) and transferred
onto nitrocellulose membranes. Immunodetection involved spe-
cific primary antibodies, appropriate secondary antibodies conju-
gated to horseradish peroxidase, and a chemiluminescent Western
blotting detection system (GE Healthcare Bio-Sciences, Corp.,
Piscataway, NJ). For bar graphs, at least three independent
Western blots were scanned, and band intensity was measured
using Adobe Photoshop CS4. Fold change was calculated by
comparing to appropriate controls after subtracting the back-
ground.
siRNA-Mediated Knockdown of LSP1
Small interference RNA-mediated knockdown of LSP1 was
performed using SMARTpool duplex RNA oligonucleotides
(Dharmacon, Lafayette, CO) with the following four target
sequences: GUAACAGUGUGAAGAAAUC, GAAGAG-
GUAUAAGUUUGUG, AUCAGUGGCUGGAACAAUA,
CUAAACCGCUCCAUAGAGA. A non-targeting siRNA (target
DNA sequence: AATTCTCCGAACGTGTCACGT) from Qia-
gen (Valencia, CA) was used as the negative control. siRNAs were
transfected into iMDDCs by nucleofection (Lonza Wakersville Inc,
Wakersville, MD) per manufacturer’s instructions.
Transwell and Transendothelial Migration Assays
iMDDCs were pretreated with Slit2N (1 mg/ml) or a negative
control (1 mg/ml) for 2 hours in RPMI 1640 (0.5% BSA).
Approximately 5610
5 cells were added to the upper compartment
of 24-well transwell chambers (5 mm pores) (Corning Costar Corp,
Cambridge, MA). Medium (600 ml), +/2 M-gp120 (10 nM) or
Slit2N (1 mg/ml), was added to the lower compartments. After
3 hours at 37uC, 5% CO2, cells in the lower compartments were
counted using a hemocytometer. For the transendothelial migra-
tion assay, HUVECs (2610
5 cells) were cultured (without
stimulation) onto the membrane in the upper compartments of
the transwell chambers for 2 days before the start of the
experiment. The integrity of confluent HUVEC monolayers was
assessed by microscopy. The remainder of the assay was executed
as described above, except iMDDCs were incubated for 8 hours
before assessing migration. The data are expressed as the percent
of cells that migrated to the lower compartments divided by the
total number of cells seeded to the top compartments.
Confocal Microscopy
iMDDCs were cultured on chamber slides. They were
pretreated with Slit2N (1 mg/ml) or PBS for 2 hours in RPMI
1640 (0.5% BSA), then incubated with M-gp120 (10 nM) or PBS
for 1 hour in RPMI 1640 (0.5% BSA). They were fixed at RT in
4% paraformaldehyde (15 minutes) and blocked with 5% normal
goat serum in PBS/Triton (1 hour). Cells were then incubated
with an anti-LSP1 monoclonal antibody or anti-Robo1 antibody,
and/or antibodies to vinculin, b-actin, WASp and/or Arp2
overnight at 4uC, washed thrice with PBS, and stained with
AlexaFluor 568–labeled anti–mouse IgG antibody (Molecular
ProbesH; Invitrogen) and/or AlexaFluor 488 phalloidin (Molecular
Probes) for 2 hours. Subsequently, cells were washed thrice with
PBS, and slides were mounted using Prolong Gold antifade with
DAPI (49,6-diamidino-2-phenylindole; Invitrogen). Slides were
examined under a Zeiss 510 Meta confocal microscope (Carl Zeiss
Microimaging, LLC, Thornwood, NY), and images were acquired
using LSM 510 software (Carl Zeiss).
Percent Area Covered by Podosomes per Cell and
Number of Podosomes per Cell
The area covered by podosomes per cell was assessed using the
‘‘find object’’ function of VolocityH software (PerkinElmer,
Waltham, MA). The borders of each podosome were drawn by
hand. The total area of podosomes, and the percentage area
covered by podosomes for individual cells was calculated using
VolocityH software. To determine the number of podosomes per
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objects’’ function in VolocityH, with verification and correction by
eye.
Quantification of Protein Colocalization
Protein colocalization was quantified using confocal microscopy
and VolocityH software. Briefly, the Manders (M) coefficient,
which represents the percentage of pixels in the red channel which
intersect with signal in the green channel was set to ‘‘1’’ in
untreated cells, and fold change in protein colocalization in treated
cells was calculated relative to this control.
CDC42 and Rac1 Activation Assay
CDC42 and Rac1 activation were determined using the Rac/
Cdc42 activation assay kit (SGT445, Upstate Biotechnology,
Waltham, MA). In brief, cell lysates were incubated with 15 mg/ml
p21-activated kinase (PAK)-1 agarose for 1 hour at 4uC, per
manufacturer’s instructions. Agarose beads were collected by
centrifugation, followed by denaturation, boiling of the samples,
and SDS-PAGE analysis. Proteins were transferred to nitrocellu-
lose membranes, and Western blot analysis was performed using
mouse anti-human CDC42 or Rac1 antibody.
Statistical Analysis
Results are expressed as the mean 6 SD of data from 3 or more
independent experiments (as stated), using Student’s 2-tailed,
paired, t-test. p#0.05 was considered statistically significant.
Supporting Information
Figure S1 Slit2N inhibits M-gp120-induced colocaliza-
tion of LSP1, WASp, Arp2/3, and b-actin to iMDDC
podosomes. Colocalization of LSP1 with WASp, Arp2/3 and b-
actin by confocal microscopy. iMDDCs were cultured on chamber
slides and left untreated or incubated with M-gp120, Slit2N then
M-gp120, or Slit2N alone (Slit2N incubation: 2 hours; M-gp120
incubation: 1 hour) before fixing and staining cells. Yellow/
orange/red = merge of LSP1 and WASp, Arp2/3 or b-actin, as
indicated; Scale bars =5 mm. Representative images are shown.
(TIF)
Figure S2 Slit2N, but not M-gp120, enhances the
colocalization of Robo1 with WASp and LSP1 in
iMDDCs. Colocalization of Robo1 with WASp and LSP1 by
confocal microscopy. iMDDCs were cultured on chamber slides
and left untreated or incubated with M-gp120, Slit2N then M-
gp120, or Slit2N alone (Slit2N incubation: 2 hours; M-gp120
incubation: 1 hour) before fixing and staining cells. Yellow/
orange = merge of Robo1 and WASp or LSP1, as indicated.
Scale bars =5 mm. Representative images are shown.
(TIF)
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